Abstract:BackgroundMethotrexate (MTX) is the gold standard as first line treatment in rheumatoid arthritis (RA). Identifying predictors of response to MTX should be crucial in the view of a personalized therapy.ObjectivesTo identify prevalence and potential clinical baseline predictors of inadequate response (IR) to MTX in RA patients naïve to disease modifying anti-rheumatic drugs (DMARDs)*.MethodsData of 233 consecutive RA patients (according to ACR/EULAR 2010 criteria) naïve to traditional and biologic DMARDs, atten… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.